NPR - The Food and Drug Administration's top vaccine advisory
committee voted unanimously yesterday to recommend Moderna's new mRNA
influenza vaccine for adults 50 and over. This was the first
time it reviewed a new vaccine application since 2023.
NPR - The Food and Drug Administration's top vaccine advisory
committee voted unanimously yesterday to recommend Moderna's new mRNA
influenza vaccine for adults 50 and over. This was the first
time it reviewed a new vaccine application since 2023.
No comments:
Post a Comment